The Cooper Companies(US:COO) ZACKSยท2025-03-07 00:00Core Insights - The Cooper Companies reported revenue of $964.7 million for the quarter ended January 2025, reflecting a year-over-year increase of 3.6% [1] - The earnings per share (EPS) for the quarter was $0.92, up from $0.85 in the same quarter last year, aligning with the consensus EPS estimate [1] - The reported revenue fell short of the Zacks Consensus Estimate of $981.48 million, resulting in a surprise of -1.71% [1] Financial Performance Metrics - The Cooper Companies' stock has returned -5.5% over the past month, underperforming the Zacks S&P 500 composite's -3.5% change, and currently holds a Zacks Rank 4 (Sell) [3] - Revenue by Geography: - Americas: $270.90 million, exceeding the average estimate of $260.53 million, with a year-over-year change of +7.2% [4] - Asia Pacific: $128.70 million, below the average estimate of $138.64 million, representing a year-over-year change of -1.5% [4] - EMEA: $246.50 million, below the average estimate of $257.60 million, with a year-over-year change of +3.5% [4] - Revenue by Category: - CVI: $646.10 million, slightly below the average estimate of $656.01 million, with a year-over-year change of +4% [4] - CSI: $318.60 million, below the average estimate of $326.91 million, reflecting a year-over-year change of +2.7% [4] - CSI- Office and surgical: $198.90 million, slightly above the average estimate of $198.50 million, with a year-over-year change of +4.1% [4] - CSI- Fertility: $119.70 million, below the average estimate of $129.05 million, with a year-over-year change of +0.6% [4] - CVI- Sphere, other: $326.70 million, below the average estimate of $339.31 million [4] - CVI- Toric and multifocal: $319.40 million, slightly above the average estimate of $318.23 million [4]